Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ovarian Function in HNF1B Mutation Carriers
NCT04746053Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Apr 2021
- Primary completion
- Oct 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Antimullerian Hormone at day 1. Started Apr 2021; status: completed.
Beyond the preview
Go deeper on NCT04746053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04746053.